Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 4.54121257 |
2 | Golgi transport vesicle coating (GO:0048200) | 4.54121257 |
3 | neutrophil activation involved in immune response (GO:0002283) | 4.12426332 |
4 | signal peptide processing (GO:0006465) | 3.93719157 |
5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.90260056 |
6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.80703385 |
7 | ATP synthesis coupled proton transport (GO:0015986) | 3.80703385 |
8 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.69632393 |
9 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.62205611 |
10 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.62205611 |
11 | protein retention in ER lumen (GO:0006621) | 3.60790194 |
12 | regulation of autophagic vacuole assembly (GO:2000785) | 3.56777405 |
13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.48565902 |
14 | respiratory electron transport chain (GO:0022904) | 3.37932956 |
15 | electron transport chain (GO:0022900) | 3.34423465 |
16 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.32056689 |
17 | protein complex biogenesis (GO:0070271) | 3.28351211 |
18 | immunoglobulin mediated immune response (GO:0016064) | 3.22355850 |
19 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.20920012 |
20 | sequestering of metal ion (GO:0051238) | 3.19420001 |
21 | regulation of vacuole organization (GO:0044088) | 3.18046542 |
22 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.16867516 |
23 | low-density lipoprotein particle clearance (GO:0034383) | 3.16198372 |
24 | amyloid precursor protein catabolic process (GO:0042987) | 3.13709384 |
25 | viral protein processing (GO:0019082) | 3.09409280 |
26 | platelet dense granule organization (GO:0060155) | 3.08580861 |
27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.02959556 |
28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.02959556 |
29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.02959556 |
30 | modulation by symbiont of host immune response (GO:0052553) | 3.02959556 |
31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.02959556 |
32 | modulation by symbiont of host defense response (GO:0052031) | 3.02959556 |
33 | hydrogen ion transmembrane transport (GO:1902600) | 3.01701678 |
34 | epithelial cilium movement (GO:0003351) | 2.94957910 |
35 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.94325131 |
36 | aldehyde catabolic process (GO:0046185) | 2.91531943 |
37 | eosinophil chemotaxis (GO:0048245) | 2.89350687 |
38 | respiratory burst (GO:0045730) | 2.87944219 |
39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86456245 |
40 | positive regulation of mast cell degranulation (GO:0043306) | 2.86456245 |
41 | positive regulation of mast cell activation (GO:0033005) | 2.82984178 |
42 | proton transport (GO:0015992) | 2.81393759 |
43 | COPII vesicle coating (GO:0048208) | 2.78165080 |
44 | hydrogen transport (GO:0006818) | 2.77954174 |
45 | response to peptidoglycan (GO:0032494) | 2.77214496 |
46 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.76442182 |
47 | NADH dehydrogenase complex assembly (GO:0010257) | 2.76442182 |
48 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.76442182 |
49 | transferrin transport (GO:0033572) | 2.75202615 |
50 | microglial cell activation (GO:0001774) | 2.75095777 |
51 | amino sugar catabolic process (GO:0046348) | 2.71472811 |
52 | nucleobase catabolic process (GO:0046113) | 2.71386618 |
53 | reactive oxygen species biosynthetic process (GO:1903409) | 2.66975532 |
54 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.66904523 |
55 | eosinophil migration (GO:0072677) | 2.66644462 |
56 | ferric iron transport (GO:0015682) | 2.64876800 |
57 | trivalent inorganic cation transport (GO:0072512) | 2.64876800 |
58 | protein maturation by protein folding (GO:0022417) | 2.64391659 |
59 | adaptation of signaling pathway (GO:0023058) | 2.63537620 |
60 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.59504991 |
61 | chaperone-mediated protein transport (GO:0072321) | 2.58216474 |
62 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.57083458 |
63 | negative regulation of cell killing (GO:0031342) | 2.54574225 |
64 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.54574225 |
65 | granulocyte activation (GO:0036230) | 2.53312195 |
66 | behavioral response to nicotine (GO:0035095) | 2.51408802 |
67 | protein neddylation (GO:0045116) | 2.51317181 |
68 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.48801692 |
69 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.48688995 |
70 | positive regulation of TOR signaling (GO:0032008) | 2.48306766 |
71 | keratan sulfate catabolic process (GO:0042340) | 2.48268083 |
72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.44033706 |
73 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.43465385 |
74 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.43037344 |
75 | protein localization to cilium (GO:0061512) | 2.42297740 |
76 | regulation of mast cell activation (GO:0033003) | 2.40123184 |
77 | cytochrome complex assembly (GO:0017004) | 2.40017989 |
78 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.39879854 |
79 | neutrophil activation (GO:0042119) | 2.38634310 |
80 | cilium movement (GO:0003341) | 2.38483670 |
81 | phagosome maturation (GO:0090382) | 2.36896054 |
82 | macrophage activation involved in immune response (GO:0002281) | 2.36869130 |
83 | regulation of mast cell degranulation (GO:0043304) | 2.35442030 |
84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.35232266 |
85 | adhesion of symbiont to host cell (GO:0044650) | 2.35123521 |
86 | virion attachment to host cell (GO:0019062) | 2.35123521 |
87 | ATP biosynthetic process (GO:0006754) | 2.34944575 |
88 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.34201815 |
89 | regulation of cholesterol storage (GO:0010885) | 2.31233262 |
90 | detection of bacterium (GO:0016045) | 2.30515058 |
91 | adhesion of symbiont to host (GO:0044406) | 2.30102852 |
92 | L-phenylalanine catabolic process (GO:0006559) | 2.29924794 |
93 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.29924794 |
94 | regulation of mononuclear cell migration (GO:0071675) | 2.29340473 |
95 | regulation of cilium movement (GO:0003352) | 2.28544234 |
96 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.27956405 |
97 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.27919702 |
98 | positive regulation of interferon-alpha production (GO:0032727) | 2.27458306 |
99 | negative regulation of interleukin-12 production (GO:0032695) | 2.26751364 |
100 | detection of other organism (GO:0098543) | 2.26356639 |
101 | apoptotic cell clearance (GO:0043277) | 2.26106111 |
102 | regulation of monocyte chemotaxis (GO:0090025) | 2.25581607 |
103 | xenobiotic catabolic process (GO:0042178) | 2.25486056 |
104 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.24409518 |
105 | endocrine pancreas development (GO:0031018) | 2.24173873 |
106 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.23956169 |
107 | virion assembly (GO:0019068) | 2.23871373 |
108 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.21875648 |
109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.21875648 |
110 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.20955287 |
111 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.20281322 |
112 | protein carboxylation (GO:0018214) | 2.20223226 |
113 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.20223226 |
114 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.19557806 |
115 | axoneme assembly (GO:0035082) | 2.18892602 |
116 | peptide hormone processing (GO:0016486) | 2.18719745 |
117 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.17985620 |
118 | positive regulation of antigen processing and presentation (GO:0002579) | 2.17908258 |
119 | plasma lipoprotein particle clearance (GO:0034381) | 2.17683577 |
120 | regulation of interferon-alpha production (GO:0032647) | 2.17610512 |
121 | cellular response to zinc ion (GO:0071294) | 2.17360442 |
122 | regulation of podosome assembly (GO:0071801) | 2.16546091 |
123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.16538010 |
124 | respiratory chain complex IV assembly (GO:0008535) | 2.16337477 |
125 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.16116887 |
126 | detection of molecule of bacterial origin (GO:0032490) | 2.15852414 |
127 | cellular response to vitamin D (GO:0071305) | 2.15618116 |
128 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.15558204 |
129 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.15479458 |
130 | sequestering of actin monomers (GO:0042989) | 2.14888481 |
131 | 4-hydroxyproline metabolic process (GO:0019471) | 2.14543434 |
132 | mitochondrion degradation (GO:0000422) | 2.14307219 |
133 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.14290025 |
134 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.14267458 |
135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.14049916 |
136 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.13811485 |
137 | L-phenylalanine metabolic process (GO:0006558) | 2.13581435 |
138 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.13581435 |
139 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.12377094 |
140 | response to host immune response (GO:0052572) | 2.12377094 |
141 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.11271512 |
142 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.10935561 |
143 | neutrophil mediated immunity (GO:0002446) | 2.10782755 |
144 | positive regulation of nuclease activity (GO:0032075) | 2.09583459 |
145 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.09336919 |
146 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.08762192 |
147 | regulation of microtubule-based movement (GO:0060632) | 2.08657657 |
148 | cellular response to unfolded protein (GO:0034620) | 2.08449748 |
149 | potassium ion export (GO:0071435) | 2.08404460 |
150 | cofactor catabolic process (GO:0051187) | 2.08346503 |
151 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.08088279 |
152 | superoxide anion generation (GO:0042554) | 2.07990099 |
153 | hydrogen peroxide catabolic process (GO:0042744) | 2.07252302 |
154 | amyloid precursor protein metabolic process (GO:0042982) | 2.07131660 |
155 | cellular response to nicotine (GO:0071316) | 2.07031686 |
156 | T-helper 1 type immune response (GO:0042088) | 2.06827232 |
157 | macrophage activation (GO:0042116) | 2.06634870 |
158 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.06504158 |
159 | cellular response to vitamin (GO:0071295) | 2.06288813 |
160 | mitochondrial calcium ion transport (GO:0006851) | 2.06028018 |
161 | exocrine pancreas development (GO:0031017) | 2.05733744 |
162 | regulation of antigen processing and presentation (GO:0002577) | 2.05239153 |
163 | vesicle coating (GO:0006901) | 2.05087516 |
164 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.03859054 |
165 | negative regulation of cation channel activity (GO:2001258) | 2.02655651 |
166 | response to interferon-beta (GO:0035456) | 2.02375994 |
167 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.01795983 |
168 | regulation of synapse structural plasticity (GO:0051823) | 2.01658781 |
169 | regulation of metalloenzyme activity (GO:0048552) | 2.01146687 |
170 | positive regulation of leukocyte degranulation (GO:0043302) | 2.01100748 |
171 | hydrogen peroxide metabolic process (GO:0042743) | 2.01062225 |
172 | peptide catabolic process (GO:0043171) | 2.00315191 |
173 | intestinal cholesterol absorption (GO:0030299) | 1.99583197 |
174 | intracellular pH reduction (GO:0051452) | 1.97997545 |
175 | cellular response to topologically incorrect protein (GO:0035967) | 1.97716662 |
176 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 1.96753046 |
177 | pH reduction (GO:0045851) | 1.96535289 |
178 | ER-nucleus signaling pathway (GO:0006984) | 1.96407958 |
179 | positive regulation of p38MAPK cascade (GO:1900745) | 1.96307493 |
180 | growth hormone receptor signaling pathway (GO:0060396) | 1.95290972 |
181 | toxin metabolic process (GO:0009404) | 1.94307179 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.77739923 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.47672854 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.36991037 |
4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.36339278 |
5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.97672454 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.97045911 |
7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.89972615 |
8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.84582026 |
9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72007371 |
10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.66938343 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.50743884 |
12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41932793 |
13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35157523 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35136939 |
15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.34265846 |
16 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.32482631 |
17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.30764497 |
18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29463977 |
19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.25430876 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10082971 |
21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.07412115 |
22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.99316201 |
23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.97099382 |
24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94071184 |
25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.91316701 |
26 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.89112806 |
27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.78511030 |
28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77792995 |
29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73754098 |
30 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72838601 |
31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68329294 |
32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68105992 |
33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68023495 |
34 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.61040698 |
35 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.60900855 |
36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60381754 |
37 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.60069189 |
38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57788359 |
39 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54502978 |
40 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54502978 |
41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52747372 |
42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50654964 |
43 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50137312 |
44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49679416 |
45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49075903 |
46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47872200 |
47 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.45690302 |
48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45328684 |
49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44797221 |
50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.44622113 |
51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42267905 |
52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38946529 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36422675 |
54 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.33441345 |
55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32893623 |
56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.32804770 |
57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31836773 |
58 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.31630269 |
59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.31148691 |
60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.31099733 |
61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30968151 |
62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30521418 |
63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27806220 |
64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27319354 |
65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25514481 |
66 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.24965184 |
67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24862950 |
68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24838345 |
69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24558080 |
70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23055050 |
71 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.22716172 |
72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21108889 |
73 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.19352303 |
74 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.19204740 |
75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19133977 |
76 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.18950980 |
77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17270538 |
78 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.17213650 |
79 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16127446 |
80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15772289 |
81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15536077 |
82 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15426497 |
83 | ERA_21632823_ChIP-Seq_H3396_Human | 1.13274668 |
84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13122570 |
85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12566993 |
86 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11891365 |
87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11633158 |
88 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11562076 |
89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11139771 |
90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09420943 |
91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08824221 |
92 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.08577091 |
93 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07826239 |
94 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06748890 |
95 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.06669373 |
96 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06510791 |
97 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.06164421 |
98 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06113097 |
99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05979022 |
100 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05834283 |
101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05067767 |
102 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04590327 |
103 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04566690 |
104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04552086 |
105 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04468027 |
106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04122372 |
107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04116750 |
108 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03461108 |
109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02102734 |
110 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.01840710 |
111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01293157 |
112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00976480 |
113 | P300_27268052_Chip-Seq_Bcells_Human | 1.00671017 |
114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.99676076 |
115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99282133 |
116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98241296 |
117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96884374 |
118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96383304 |
119 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95871757 |
120 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95558013 |
121 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94918839 |
122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94710973 |
123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94268065 |
124 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94042115 |
125 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.93427083 |
126 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93076012 |
127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92989880 |
128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92472305 |
129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91970776 |
130 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91636076 |
131 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91405761 |
132 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.91361362 |
133 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90701058 |
134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90631132 |
135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90175712 |
136 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.89908263 |
137 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89767358 |
138 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89578327 |
139 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.89417180 |
140 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89382369 |
141 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88952431 |
142 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88745989 |
143 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88665041 |
144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88460233 |
145 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87989637 |
146 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87547403 |
147 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.87413956 |
148 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87220590 |
149 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.86622090 |
150 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.85831223 |
151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85800587 |
152 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85478311 |
153 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.85039807 |
154 | NCOR_22424771_ChIP-Seq_293T_Human | 0.85026145 |
155 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.84719979 |
156 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84624786 |
157 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84520962 |
158 | AR_20517297_ChIP-Seq_VCAP_Human | 0.84510040 |
159 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84483756 |
160 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83984622 |
161 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.83570399 |
162 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.83223654 |
163 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82999685 |
164 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82871601 |
165 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.82776758 |
166 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.82672280 |
167 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81483600 |
168 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79619282 |
169 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79366638 |
170 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78392266 |
171 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77657723 |
172 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.76362553 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 3.64530243 |
2 | MP0008438_abnormal_cutaneous_collagen | 3.19113430 |
3 | MP0003436_decreased_susceptibility_to | 2.73142347 |
4 | MP0002653_abnormal_ependyma_morphology | 2.57837694 |
5 | MP0003195_calcinosis | 2.56618385 |
6 | MP0003011_delayed_dark_adaptation | 2.56254589 |
7 | MP0006082_CNS_inflammation | 2.32683001 |
8 | MP0005083_abnormal_biliary_tract | 2.32663501 |
9 | MP0003724_increased_susceptibility_to | 2.27853227 |
10 | MP0003880_abnormal_central_pattern | 2.27716042 |
11 | MP0002148_abnormal_hypersensitivity_rea | 2.19208082 |
12 | MP0001835_abnormal_antigen_presentation | 2.12686348 |
13 | MP0009840_abnormal_foam_cell | 2.10990566 |
14 | MP0002139_abnormal_hepatobiliary_system | 2.09071669 |
15 | MP0009785_altered_susceptibility_to | 2.05342626 |
16 | MP0001533_abnormal_skeleton_physiology | 2.00528511 |
17 | MP0002822_catalepsy | 1.97668277 |
18 | MP0010386_abnormal_urinary_bladder | 1.94390306 |
19 | MP0002419_abnormal_innate_immunity | 1.87732544 |
20 | MP0003300_gastrointestinal_ulcer | 1.87293489 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.86667281 |
22 | MP0001905_abnormal_dopamine_level | 1.83912792 |
23 | MP0003787_abnormal_imprinting | 1.79818272 |
24 | MP0003183_abnormal_peptide_metabolism | 1.75300531 |
25 | MP0003303_peritoneal_inflammation | 1.75022924 |
26 | MP0005000_abnormal_immune_tolerance | 1.74580005 |
27 | MP0005275_abnormal_skin_tensile | 1.73254468 |
28 | MP0002277_abnormal_respiratory_mucosa | 1.71426432 |
29 | MP0003186_abnormal_redox_activity | 1.70252160 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.68594628 |
31 | MP0002877_abnormal_melanocyte_morpholog | 1.66978874 |
32 | MP0006276_abnormal_autonomic_nervous | 1.64141914 |
33 | MP0003172_abnormal_lysosome_physiology | 1.63789901 |
34 | MP0002638_abnormal_pupillary_reflex | 1.63372706 |
35 | MP0005360_urolithiasis | 1.58054982 |
36 | MP0001790_abnormal_immune_system | 1.57228075 |
37 | MP0005387_immune_system_phenotype | 1.57228075 |
38 | MP0009643_abnormal_urine_homeostasis | 1.56978469 |
39 | MP0005025_abnormal_response_to | 1.56247366 |
40 | MP0004043_abnormal_pH_regulation | 1.56191213 |
41 | MP0000343_altered_response_to | 1.53775353 |
42 | MP0005365_abnormal_bile_salt | 1.53487627 |
43 | MP0004142_abnormal_muscle_tone | 1.52604657 |
44 | MP0002102_abnormal_ear_morphology | 1.51494968 |
45 | MP0000685_abnormal_immune_system | 1.48711568 |
46 | MP0000013_abnormal_adipose_tissue | 1.48546918 |
47 | MP0001958_emphysema | 1.48358884 |
48 | MP0002933_joint_inflammation | 1.46337374 |
49 | MP0003279_aneurysm | 1.44050940 |
50 | MP0003122_maternal_imprinting | 1.42385099 |
51 | MP0002837_dystrophic_cardiac_calcinosis | 1.40440200 |
52 | MP0002998_abnormal_bone_remodeling | 1.40251149 |
53 | MP0009764_decreased_sensitivity_to | 1.40131336 |
54 | MP0001970_abnormal_pain_threshold | 1.39113798 |
55 | MP0002693_abnormal_pancreas_physiology | 1.38684577 |
56 | MP0003705_abnormal_hypodermis_morpholog | 1.36561899 |
57 | MP0006054_spinal_hemorrhage | 1.35156929 |
58 | MP0006036_abnormal_mitochondrial_physio | 1.33977326 |
59 | MP0002064_seizures | 1.33546168 |
60 | MP0005220_abnormal_exocrine_pancreas | 1.33367275 |
61 | MP0003879_abnormal_hair_cell | 1.32267554 |
62 | MP0008469_abnormal_protein_level | 1.31076815 |
63 | MP0005257_abnormal_intraocular_pressure | 1.30218836 |
64 | MP0001666_abnormal_nutrient_absorption | 1.30037794 |
65 | MP0002295_abnormal_pulmonary_circulatio | 1.29908711 |
66 | MP0005503_abnormal_tendon_morphology | 1.29376143 |
67 | MP0001845_abnormal_inflammatory_respons | 1.29352106 |
68 | MP0009379_abnormal_foot_pigmentation | 1.28692476 |
69 | MP0001529_abnormal_vocalization | 1.28636971 |
70 | MP0004947_skin_inflammation | 1.26950569 |
71 | MP0009745_abnormal_behavioral_response | 1.22916837 |
72 | MP0001986_abnormal_taste_sensitivity | 1.22610609 |
73 | MP0005253_abnormal_eye_physiology | 1.22501554 |
74 | MP0003075_altered_response_to | 1.22316122 |
75 | MP0002272_abnormal_nervous_system | 1.22142965 |
76 | MP0005464_abnormal_platelet_physiology | 1.21868452 |
77 | MP0002733_abnormal_thermal_nociception | 1.21547260 |
78 | MP0002876_abnormal_thyroid_physiology | 1.20875370 |
79 | MP0009046_muscle_twitch | 1.19809486 |
80 | MP0006072_abnormal_retinal_apoptosis | 1.19571665 |
81 | MP0001756_abnormal_urination | 1.19410359 |
82 | MP0005390_skeleton_phenotype | 1.18728480 |
83 | MP0004510_myositis | 1.18286206 |
84 | MP0005310_abnormal_salivary_gland | 1.17792726 |
85 | MP0005085_abnormal_gallbladder_physiolo | 1.14700234 |
86 | MP0002452_abnormal_antigen_presenting | 1.13392943 |
87 | MP0005164_abnormal_response_to | 1.13213416 |
88 | MP0000604_amyloidosis | 1.12902166 |
89 | MP0003806_abnormal_nucleotide_metabolis | 1.12173346 |
90 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11311084 |
91 | MP0005332_abnormal_amino_acid | 1.11305396 |
92 | MP0005636_abnormal_mineral_homeostasis | 1.10105538 |
93 | MP0002132_abnormal_respiratory_system | 1.09980037 |
94 | MP0003795_abnormal_bone_structure | 1.08280990 |
95 | MP0001984_abnormal_olfaction | 1.08242873 |
96 | MP0005075_abnormal_melanosome_morpholog | 1.07094437 |
97 | MP0001944_abnormal_pancreas_morphology | 1.06034535 |
98 | MP0003656_abnormal_erythrocyte_physiolo | 1.05741221 |
99 | MP0002723_abnormal_immune_serum | 1.05423300 |
100 | MP0003252_abnormal_bile_duct | 1.05422843 |
101 | MP0005645_abnormal_hypothalamus_physiol | 1.04993704 |
102 | MP0005167_abnormal_blood-brain_barrier | 1.04385987 |
103 | MP0001542_abnormal_bone_strength | 1.04384581 |
104 | MP0005084_abnormal_gallbladder_morpholo | 1.03722891 |
105 | MP0003633_abnormal_nervous_system | 1.03506117 |
106 | MP0002896_abnormal_bone_mineralization | 1.03358265 |
107 | MP0002118_abnormal_lipid_homeostasis | 1.03313447 |
108 | MP0005551_abnormal_eye_electrophysiolog | 1.02895572 |
109 | MP0005535_abnormal_body_temperature | 1.01945700 |
110 | MP0008789_abnormal_olfactory_epithelium | 1.01539261 |
111 | MP0001486_abnormal_startle_reflex | 1.01029235 |
112 | MP0002572_abnormal_emotion/affect_behav | 1.00037333 |
113 | MP0001968_abnormal_touch/_nociception | 0.99635801 |
114 | MP0004270_analgesia | 0.99599626 |
115 | MP0002405_respiratory_system_inflammati | 0.98285563 |
116 | MP0000538_abnormal_urinary_bladder | 0.98234604 |
117 | MP0002909_abnormal_adrenal_gland | 0.98092739 |
118 | MP0003635_abnormal_synaptic_transmissio | 0.98081340 |
119 | MP0003566_abnormal_cell_adhesion | 0.97602116 |
120 | MP0005423_abnormal_somatic_nervous | 0.95569305 |
121 | MP0005499_abnormal_olfactory_system | 0.94062632 |
122 | MP0005394_taste/olfaction_phenotype | 0.94062632 |
123 | MP0004885_abnormal_endolymph | 0.92770379 |
124 | MP0005319_abnormal_enzyme/_coenzyme | 0.90894454 |
125 | MP0002136_abnormal_kidney_physiology | 0.90636828 |
126 | MP0010329_abnormal_lipoprotein_level | 0.89871337 |
127 | MP0003866_abnormal_defecation | 0.89747256 |
128 | MP0000609_abnormal_liver_physiology | 0.89004373 |
129 | MP0002063_abnormal_learning/memory/cond | 0.88929946 |
130 | MP0004019_abnormal_vitamin_homeostasis | 0.88667113 |
131 | MP0002557_abnormal_social/conspecific_i | 0.87852409 |
132 | MP0001819_abnormal_immune_cell | 0.87704108 |
133 | MP0002078_abnormal_glucose_homeostasis | 0.87674075 |
134 | MP0001765_abnormal_ion_homeostasis | 0.86876791 |
135 | MP0002734_abnormal_mechanical_nocicepti | 0.86849575 |
136 | MP0004859_abnormal_synaptic_plasticity | 0.86543026 |
137 | MP0003690_abnormal_glial_cell | 0.86360837 |
138 | MP0002420_abnormal_adaptive_immunity | 0.86041812 |
139 | MP0005671_abnormal_response_to | 0.85965323 |
140 | MP0000858_altered_metastatic_potential | 0.85902201 |
141 | MP0004782_abnormal_surfactant_physiolog | 0.85866544 |
142 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85765148 |
143 | MP0002229_neurodegeneration | 0.85522848 |
144 | MP0001501_abnormal_sleep_pattern | 0.85086358 |
145 | MP0004133_heterotaxia | 0.84601298 |
146 | MP0003448_altered_tumor_morphology | 0.84348629 |
147 | MP0004742_abnormal_vestibular_system | 0.84229654 |
148 | MP0005166_decreased_susceptibility_to | 0.83859703 |
149 | MP0001800_abnormal_humoral_immune | 0.81965958 |
150 | MP0005379_endocrine/exocrine_gland_phen | 0.79758310 |
151 | MP0010155_abnormal_intestine_physiology | 0.77397101 |
152 | MP0000249_abnormal_blood_vessel | 0.75778517 |
153 | MP0004272_abnormal_basement_membrane | 0.75620652 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vacuolated lymphocytes (HP:0001922) | 5.13387261 |
2 | Dysostosis multiplex (HP:0000943) | 4.23173009 |
3 | Increased cerebral lipofuscin (HP:0011813) | 3.92695764 |
4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.84205291 |
5 | Polyphagia (HP:0002591) | 3.77751750 |
6 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.73594294 |
7 | Mucopolysacchariduria (HP:0008155) | 3.73594294 |
8 | Eczematoid dermatitis (HP:0000976) | 3.72531227 |
9 | Mitochondrial inheritance (HP:0001427) | 3.65891886 |
10 | Acute necrotizing encephalopathy (HP:0006965) | 3.64540210 |
11 | Systemic lupus erythematosus (HP:0002725) | 3.52906679 |
12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45768497 |
13 | Recurrent abscess formation (HP:0002722) | 3.45270317 |
14 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.37773765 |
15 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.37773765 |
16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.37773765 |
17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.34187283 |
18 | Axonal loss (HP:0003447) | 3.32653206 |
19 | Recurrent bacterial skin infections (HP:0005406) | 3.30354196 |
20 | Abnormality of macrophages (HP:0004311) | 3.23061027 |
21 | Stomatitis (HP:0010280) | 3.18811477 |
22 | Progressive macrocephaly (HP:0004481) | 3.18361068 |
23 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.10081132 |
24 | Hepatocellular necrosis (HP:0001404) | 3.08144166 |
25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.01367456 |
26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.01310452 |
27 | Renal Fanconi syndrome (HP:0001994) | 2.98538981 |
28 | Hypoglycemic coma (HP:0001325) | 2.91124685 |
29 | Increased CSF lactate (HP:0002490) | 2.89005015 |
30 | Hepatic necrosis (HP:0002605) | 2.88802595 |
31 | Mutism (HP:0002300) | 2.87418288 |
32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.87407860 |
33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.87407860 |
34 | Acute encephalopathy (HP:0006846) | 2.86645100 |
35 | Vertebral compression fractures (HP:0002953) | 2.86201721 |
36 | Agitation (HP:0000713) | 2.80303574 |
37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73905586 |
38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73905586 |
39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73905586 |
40 | Generalized aminoaciduria (HP:0002909) | 2.70719612 |
41 | Lipid accumulation in hepatocytes (HP:0006561) | 2.70120559 |
42 | Beaking of vertebral bodies (HP:0004568) | 2.63780313 |
43 | Abnormal ciliary motility (HP:0012262) | 2.60511136 |
44 | Increased hepatocellular lipid droplets (HP:0006565) | 2.60257829 |
45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58931350 |
46 | Obstructive lung disease (HP:0006536) | 2.58931350 |
47 | Exertional dyspnea (HP:0002875) | 2.53205080 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.51138022 |
49 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49815304 |
50 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.49633340 |
51 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.49633340 |
52 | Increased muscle lipid content (HP:0009058) | 2.46628273 |
53 | Xanthomatosis (HP:0000991) | 2.40027067 |
54 | Glomerulonephritis (HP:0000099) | 2.36713477 |
55 | Hypoglycemic seizures (HP:0002173) | 2.35463622 |
56 | Abnormal eating behavior (HP:0100738) | 2.34640389 |
57 | Ketoacidosis (HP:0001993) | 2.34507369 |
58 | Myokymia (HP:0002411) | 2.32402455 |
59 | Absent/shortened dynein arms (HP:0200106) | 2.32292242 |
60 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.32292242 |
61 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.29030239 |
62 | Cervical subluxation (HP:0003308) | 2.26982290 |
63 | Petechiae (HP:0000967) | 2.26018814 |
64 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.25690589 |
65 | Symptomatic seizures (HP:0011145) | 2.25657151 |
66 | Protuberant abdomen (HP:0001538) | 2.25257277 |
67 | Peritonitis (HP:0002586) | 2.24338926 |
68 | Abnormality of renal resorption (HP:0011038) | 2.24098624 |
69 | Premature rupture of membranes (HP:0001788) | 2.22394103 |
70 | Respiratory failure (HP:0002878) | 2.19049114 |
71 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17545766 |
72 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.17330736 |
73 | Methylmalonic aciduria (HP:0012120) | 2.16197328 |
74 | Ovoid vertebral bodies (HP:0003300) | 2.14100109 |
75 | Hypochromic microcytic anemia (HP:0004840) | 2.13020325 |
76 | Medial flaring of the eyebrow (HP:0010747) | 2.12585440 |
77 | Complement deficiency (HP:0004431) | 2.08642947 |
78 | Hydroxyprolinuria (HP:0003080) | 2.06157681 |
79 | Abnormality of proline metabolism (HP:0010907) | 2.06157681 |
80 | Progressive neurologic deterioration (HP:0002344) | 2.03897288 |
81 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.03330736 |
82 | Abnormality of the intrinsic pathway (HP:0010989) | 2.02930514 |
83 | Hypothermia (HP:0002045) | 2.01990417 |
84 | Gingivitis (HP:0000230) | 2.01339774 |
85 | Abnormality of midbrain morphology (HP:0002418) | 2.00998531 |
86 | Molar tooth sign on MRI (HP:0002419) | 2.00998531 |
87 | Protrusio acetabuli (HP:0003179) | 1.99252616 |
88 | Lactic acidosis (HP:0003128) | 1.99042319 |
89 | Hyperparathyroidism (HP:0000843) | 1.98808519 |
90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98693151 |
91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97713312 |
92 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.97448982 |
93 | Tetraparesis (HP:0002273) | 1.97261170 |
94 | Myocardial infarction (HP:0001658) | 1.96864610 |
95 | Abnormality of the common coagulation pathway (HP:0010990) | 1.96186723 |
96 | Prolonged neonatal jaundice (HP:0006579) | 1.95600459 |
97 | Mediastinal lymphadenopathy (HP:0100721) | 1.95486948 |
98 | Late onset (HP:0003584) | 1.95003391 |
99 | Optic disc pallor (HP:0000543) | 1.94754192 |
100 | Loss of speech (HP:0002371) | 1.93810158 |
101 | Abnormality of purine metabolism (HP:0004352) | 1.93609610 |
102 | Autoimmune thrombocytopenia (HP:0001973) | 1.93493565 |
103 | Abnormality of complement system (HP:0005339) | 1.93137664 |
104 | Ketosis (HP:0001946) | 1.93071255 |
105 | Abnormal tarsal ossification (HP:0008369) | 1.92180472 |
106 | Cerebral edema (HP:0002181) | 1.92143481 |
107 | Optic neuritis (HP:0100653) | 1.91904900 |
108 | Retrobulbar optic neuritis (HP:0100654) | 1.91904900 |
109 | Asymmetric septal hypertrophy (HP:0001670) | 1.91565905 |
110 | Limb dystonia (HP:0002451) | 1.91460384 |
111 | True hermaphroditism (HP:0010459) | 1.91166207 |
112 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.90748323 |
113 | Chronic sinusitis (HP:0011109) | 1.89949418 |
114 | Gait imbalance (HP:0002141) | 1.89556754 |
115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88724928 |
116 | Dicarboxylic aciduria (HP:0003215) | 1.88724928 |
117 | Pathologic fracture (HP:0002756) | 1.87752101 |
118 | Episodic fever (HP:0001954) | 1.87253669 |
119 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.86530529 |
120 | Joint stiffness (HP:0001387) | 1.86325510 |
121 | Retinal atrophy (HP:0001105) | 1.85727198 |
122 | Pancreatic cysts (HP:0001737) | 1.85619570 |
123 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85166881 |
124 | Disinhibition (HP:0000734) | 1.84594588 |
125 | Recurrent skin infections (HP:0001581) | 1.83462575 |
126 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.82572634 |
127 | Urticaria (HP:0001025) | 1.81989214 |
128 | Orchitis (HP:0100796) | 1.81767545 |
129 | Pancreatic fibrosis (HP:0100732) | 1.80743228 |
130 | Bone cyst (HP:0012062) | 1.80000430 |
131 | Purpura (HP:0000979) | 1.79624634 |
132 | Nephritis (HP:0000123) | 1.79069288 |
133 | Skin nodule (HP:0200036) | 1.78940935 |
134 | Joint hemorrhage (HP:0005261) | 1.78523050 |
135 | Emotional lability (HP:0000712) | 1.78413728 |
136 | Congenital primary aphakia (HP:0007707) | 1.75369341 |
137 | Neurofibrillary tangles (HP:0002185) | 1.74952445 |
138 | Abdominal distention (HP:0003270) | 1.74340273 |
139 | Hemiparesis (HP:0001269) | 1.73602622 |
140 | Hepatosplenomegaly (HP:0001433) | 1.73335128 |
141 | Myositis (HP:0100614) | 1.73184722 |
142 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72599889 |
143 | Amyloidosis (HP:0011034) | 1.72408422 |
144 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70711076 |
145 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.70363709 |
146 | Exocrine pancreatic insufficiency (HP:0001738) | 1.69837542 |
147 | Hyperactive renin-angiotensin system (HP:0000841) | 1.68637428 |
148 | Thoracolumbar scoliosis (HP:0002944) | 1.68028589 |
149 | Hypophosphatemia (HP:0002148) | 1.67946931 |
150 | Gout (HP:0001997) | 1.67697640 |
151 | Exercise intolerance (HP:0003546) | 1.67558308 |
152 | Cupped ribs (HP:0000887) | 1.67475344 |
153 | Elevated alkaline phosphatase (HP:0003155) | 1.66996755 |
154 | Poor head control (HP:0002421) | 1.65671028 |
155 | Abolished electroretinogram (ERG) (HP:0000550) | 1.64888406 |
156 | Mitral stenosis (HP:0001718) | 1.64693126 |
157 | Glycosuria (HP:0003076) | 1.64472847 |
158 | Abnormality of urine glucose concentration (HP:0011016) | 1.64472847 |
159 | Supranuclear gaze palsy (HP:0000605) | 1.64053439 |
160 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.63148538 |
161 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.61537608 |
162 | Pancreatitis (HP:0001733) | 1.61232509 |
163 | Cerebral hemorrhage (HP:0001342) | 1.60917090 |
164 | Hypokalemic alkalosis (HP:0001949) | 1.60203326 |
165 | Thin bony cortex (HP:0002753) | 1.59364760 |
166 | Abnormality of chloride homeostasis (HP:0011422) | 1.59237451 |
167 | Progressive visual loss (HP:0000529) | 1.58571298 |
168 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.57403444 |
169 | Abnormal cartilage morphology (HP:0002763) | 1.56838294 |
170 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.55325091 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.47839345 |
2 | TRIB3 | 2.70970151 |
3 | TBK1 | 2.45379006 |
4 | PINK1 | 2.34640734 |
5 | EPHB1 | 2.28082093 |
6 | PIM2 | 2.25402706 |
7 | STK16 | 2.16570485 |
8 | TESK1 | 2.14083127 |
9 | BLK | 2.10881841 |
10 | CDK19 | 2.10653147 |
11 | DYRK2 | 2.09682033 |
12 | IRAK3 | 1.98140034 |
13 | EPHA3 | 1.95394153 |
14 | BCKDK | 1.92982613 |
15 | MAPK15 | 1.83674341 |
16 | ADRBK2 | 1.78905840 |
17 | MAP4K2 | 1.78161076 |
18 | INSRR | 1.76522881 |
19 | MAP3K14 | 1.73565621 |
20 | WNK4 | 1.70950762 |
21 | ARAF | 1.70342014 |
22 | TNK2 | 1.69636534 |
23 | VRK2 | 1.63846335 |
24 | PBK | 1.63027525 |
25 | IRAK4 | 1.61164159 |
26 | TAOK3 | 1.60869178 |
27 | NME2 | 1.60699170 |
28 | MARK1 | 1.55013456 |
29 | DAPK2 | 1.54432260 |
30 | MAP2K7 | 1.53574337 |
31 | MAP3K12 | 1.52685246 |
32 | CSNK1G3 | 1.44474783 |
33 | PIK3CG | 1.41298862 |
34 | WNK3 | 1.40873641 |
35 | TYK2 | 1.40398884 |
36 | LIMK1 | 1.39974648 |
37 | TAOK1 | 1.39921352 |
38 | CSNK1G2 | 1.39696807 |
39 | MST4 | 1.39227214 |
40 | MAP3K3 | 1.33568341 |
41 | MST1R | 1.32816374 |
42 | JAK3 | 1.31439092 |
43 | DYRK3 | 1.31315645 |
44 | IRAK1 | 1.30453059 |
45 | FES | 1.29202706 |
46 | MET | 1.28526541 |
47 | MAP3K2 | 1.27954902 |
48 | LRRK2 | 1.26859907 |
49 | GRK1 | 1.24758014 |
50 | RIPK4 | 1.24650345 |
51 | GRK6 | 1.24099970 |
52 | TGFBR2 | 1.22633317 |
53 | FGFR4 | 1.21985820 |
54 | ZAP70 | 1.18650245 |
55 | IKBKB | 1.17512848 |
56 | PTK6 | 1.15390826 |
57 | CSK | 1.12150723 |
58 | MAPK13 | 1.11739110 |
59 | FRK | 1.11099428 |
60 | IKBKE | 1.10777972 |
61 | MYLK | 1.08726922 |
62 | EPHB2 | 1.08333386 |
63 | ABL2 | 1.08330840 |
64 | MAP2K2 | 1.07369573 |
65 | CSNK1A1L | 1.06645874 |
66 | SIK1 | 1.06559886 |
67 | GRK5 | 1.04123468 |
68 | PTK2 | 1.03554583 |
69 | DDR2 | 1.00856659 |
70 | CSNK1G1 | 1.00496513 |
71 | JAK1 | 0.98157465 |
72 | DYRK1B | 0.98110555 |
73 | MAP3K4 | 0.97713689 |
74 | NEK9 | 0.96834743 |
75 | FLT3 | 0.96774527 |
76 | TXK | 0.96397846 |
77 | CASK | 0.94808834 |
78 | MAP3K1 | 0.93227577 |
79 | MAP2K4 | 0.93218255 |
80 | HIPK2 | 0.93153322 |
81 | MAP3K11 | 0.91677403 |
82 | NTRK1 | 0.91349413 |
83 | PHKG1 | 0.91263706 |
84 | PHKG2 | 0.91263706 |
85 | PRKG2 | 0.90594684 |
86 | TESK2 | 0.88790324 |
87 | NTRK3 | 0.84266798 |
88 | KIT | 0.84101332 |
89 | PDGFRA | 0.77207549 |
90 | ADRBK1 | 0.76729858 |
91 | BMX | 0.76318858 |
92 | STK39 | 0.75835941 |
93 | MINK1 | 0.75645079 |
94 | MAP2K3 | 0.74622354 |
95 | JAK2 | 0.74426674 |
96 | MARK3 | 0.73929151 |
97 | BTK | 0.72184242 |
98 | IRAK2 | 0.71164292 |
99 | PRKCG | 0.70860796 |
100 | CSF1R | 0.70611770 |
101 | BMPR1B | 0.70215577 |
102 | RIPK1 | 0.69830653 |
103 | HCK | 0.68574827 |
104 | ILK | 0.68493350 |
105 | PKN2 | 0.68375061 |
106 | KDR | 0.67819812 |
107 | UHMK1 | 0.67777074 |
108 | TTN | 0.67633445 |
109 | MAP4K1 | 0.65171924 |
110 | FGR | 0.65165452 |
111 | CHUK | 0.64467830 |
112 | TRPM7 | 0.62771717 |
113 | MAP2K1 | 0.62338348 |
114 | CAMKK2 | 0.61803099 |
115 | MOS | 0.60354063 |
116 | PRKCQ | 0.58638875 |
117 | MAP3K5 | 0.58096366 |
118 | PAK3 | 0.57578511 |
119 | SYK | 0.57310328 |
120 | NTRK2 | 0.56384379 |
121 | PASK | 0.56167126 |
122 | DAPK3 | 0.55497807 |
123 | BMPR2 | 0.55493703 |
124 | MAP2K6 | 0.54969004 |
125 | PRKCD | 0.54923345 |
126 | PRKCE | 0.54243186 |
127 | PKN1 | 0.54133496 |
128 | KSR2 | 0.53766370 |
129 | CDK5 | 0.52775629 |
130 | SGK494 | 0.52524059 |
131 | SGK223 | 0.52524059 |
132 | LYN | 0.52509664 |
133 | OXSR1 | 0.51898737 |
134 | MARK2 | 0.50984393 |
135 | LCK | 0.49844684 |
136 | STK11 | 0.49448598 |
137 | BCR | 0.48730809 |
138 | PRKD2 | 0.47610462 |
139 | SIK2 | 0.46562539 |
140 | MATK | 0.46373147 |
141 | GRK7 | 0.45957417 |
142 | ITK | 0.45576499 |
143 | MAPKAPK3 | 0.45523405 |
144 | FER | 0.45384578 |
145 | GSK3A | 0.45249194 |
146 | TEC | 0.45100960 |
147 | PRKD1 | 0.43946303 |
148 | RPS6KA4 | 0.43773515 |
149 | PRKCH | 0.42194489 |
150 | SCYL2 | 0.41841004 |
151 | EGFR | 0.41461570 |
152 | PTK2B | 0.41416054 |
153 | PDPK1 | 0.40892286 |
154 | MAPKAPK2 | 0.39994385 |
155 | PAK4 | 0.39897136 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 3.20127774 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.88076435 |
3 | Lysosome_Homo sapiens_hsa04142 | 2.62619488 |
4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49417517 |
5 | Huntingtons disease_Homo sapiens_hsa05016 | 2.11763218 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.10072830 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09282317 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.04300864 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.02107666 |
10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.99474151 |
11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.87112560 |
12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.83173216 |
13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73012583 |
14 | Phagosome_Homo sapiens_hsa04145 | 1.68915770 |
15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66447468 |
16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.64636281 |
17 | Ribosome_Homo sapiens_hsa03010 | 1.59724257 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.53916596 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49635875 |
20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45607010 |
21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.43162559 |
22 | Malaria_Homo sapiens_hsa05144 | 1.41568478 |
23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41406951 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.40574614 |
25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34031332 |
26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29908483 |
27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29293479 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26291620 |
29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23046738 |
30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21206735 |
31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.20965850 |
32 | Tuberculosis_Homo sapiens_hsa05152 | 1.19650079 |
33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19391876 |
34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.19040964 |
35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17647123 |
36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16250062 |
37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15434931 |
38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12146187 |
39 | Proteasome_Homo sapiens_hsa03050 | 1.10705523 |
40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03945040 |
41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03251126 |
42 | Peroxisome_Homo sapiens_hsa04146 | 1.00281938 |
43 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99673116 |
44 | Asthma_Homo sapiens_hsa05310 | 0.99557945 |
45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97639975 |
46 | Phototransduction_Homo sapiens_hsa04744 | 0.96741114 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 0.94061316 |
48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94038901 |
49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92459606 |
50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91233347 |
51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90678304 |
52 | Prion diseases_Homo sapiens_hsa05020 | 0.89238893 |
53 | * Regulation of autophagy_Homo sapiens_hsa04140 | 0.88104126 |
54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86698317 |
55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83810842 |
56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83766723 |
57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83546611 |
58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83534636 |
59 | Shigellosis_Homo sapiens_hsa05131 | 0.82591496 |
60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82409271 |
61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82078792 |
62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80240311 |
63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79875084 |
64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79098001 |
65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77053792 |
66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76722103 |
67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76060781 |
68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75456483 |
69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75176715 |
70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74418625 |
71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74190277 |
72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73470990 |
73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72375439 |
74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72200818 |
75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71756220 |
76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71490035 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71190031 |
78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70201539 |
79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70121861 |
80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70057756 |
81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69815355 |
82 | Morphine addiction_Homo sapiens_hsa05032 | 0.69412907 |
83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69276456 |
84 | Mineral absorption_Homo sapiens_hsa04978 | 0.69032822 |
85 | Insulin secretion_Homo sapiens_hsa04911 | 0.68932223 |
86 | * GABAergic synapse_Homo sapiens_hsa04727 | 0.68643302 |
87 | Allograft rejection_Homo sapiens_hsa05330 | 0.68424360 |
88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68051474 |
89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67637629 |
90 | Amoebiasis_Homo sapiens_hsa05146 | 0.67562001 |
91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67078681 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66306701 |
93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66053179 |
94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.65787967 |
95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65746166 |
96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65315420 |
97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65031362 |
98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64822823 |
99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63432555 |
100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63299988 |
101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62868700 |
102 | Nicotine addiction_Homo sapiens_hsa05033 | 0.62021770 |
103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61972215 |
104 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61418549 |
105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60943832 |
106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60289028 |
107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58913921 |
108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58558669 |
109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57600420 |
110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54098468 |
111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53432041 |
112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52679670 |
113 | Insulin resistance_Homo sapiens_hsa04931 | 0.52022684 |
114 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51851026 |
115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51813637 |
116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51526402 |
117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51291278 |
118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50870165 |
119 | Apoptosis_Homo sapiens_hsa04210 | 0.49506707 |
120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49421209 |
121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46901336 |
122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45894935 |
123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45775497 |
124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45624975 |
125 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45363355 |
126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45252431 |
127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45234344 |
128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44704287 |
129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44703030 |
130 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43714152 |
131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42959619 |
132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37467789 |
133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36257361 |
134 | Endocytosis_Homo sapiens_hsa04144 | 0.35857668 |
135 | Salivary secretion_Homo sapiens_hsa04970 | 0.35010146 |
136 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33119501 |
137 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31795400 |
138 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29184546 |
139 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27997311 |
140 | Renin secretion_Homo sapiens_hsa04924 | 0.26194057 |